Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldman Laboratories is a specialized healthcare and nutraceutical company focused on the development of advanced liposomal delivery systems for nutritional supplements. The company utilizes proprietary liposomal encapsulation technology to significantly improve the bioavailability and cellular uptake of essential nutrients compared to standard oral formulations. Their core product portfolio includes high-potency liposomal Vitamin C, Glutathione, and Vitamin D3/K2 complexes. Goldman Laboratories targets the premium wellness market, providing pharmaceutical-grade supplements designed for optimal absorption and efficacy. The company is headquartered in the United Kingdom and operates primarily within the commercial stage of the healthcare industry. By protecting nutrients from degradation in the digestive tract, their technology ensures higher concentrations reach the bloodstream and target cells.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goldman Laboratories.